Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Evelo Biosciences Announces EDP1815 to Advance into Phase 2/3 Trial

americanpharmaceuticalreviewJuly 01, 2020

Tag: Evelo Biosciences , EDP1815 , TACTIC-E

PharmaSources Customer Service